| Ident. | Authors (with country if any) | Title |
|---|
| 000592 |
Matthieu F. Bastide [France] ; Wassilios G. Meissner [France] ; Barbara Picconi [Italie] ; Stefania Fasano [Italie] ; Pierre-Olivier Fernagut [France] ; Michael Feyder [Suède] ; Veronica Francardo [Suède] ; Cristina Alcacer [Suède] ; Yunmin Ding [États-Unis] ; Riccardo Brambilla [Italie] ; Gilberto Fisone [Suède] ; A. Jon Stoessl [Canada] ; Mathieu Bourdenx [France] ; Michel Engeln [France] ; Sylvia Navailles [France] ; Philippe De Deurwaerdère [France] ; Wai Kin D. Ko [France] ; Nicola Simola [Italie] ; Micaela Morelli [Italie] ; Laurent Groc [France] ; Maria-Cruz Rodriguez [Espagne] ; Eugenia V. Gurevich [États-Unis] ; Maryka Quik [États-Unis] ; Michele Morari [Italie] ; Manuela Mellone [Italie] ; Fabrizio Gardoni [Italie] ; Elisabetta Tronci [Italie] ; Dominique Guehl [France] ; François Tison [France] ; Alan R. Crossman [Royaume-Uni] ; Un Jung Kang [Suède] ; Kathy Steece-Collier [États-Unis] ; Susan Fox [Canada] ; Manolo Carta [Italie] ; M. Angela Cenci [Suède] ; Erwan Bézard [Royaume-Uni] | Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. |
| 000849 |
Daryl J. Wile [Canada] ; Katie Dinelle [Canada] ; Nasim Vafai [Canada] ; Jessamyn Mckenzie [Canada] ; Joseph K. Tsui [Canada] ; Paul Schaffer [Canada] ; Yu-Shin Ding [États-Unis] ; Matthew Farrer [Canada] ; Vesna Sossi [Canada] ; A. Jon Stoessl [Canada] | A Scan Without Evidence Is Not Evidence of Absence: Scans Without Evidence of Dopaminergic Deficit in a Symptomatic Leucine-Rich repeat Kinase 2 Mutation Carrier |
| 000B92 |
A. Jon Stoessl [Canada] ; Stephane Lehericy [France] ; Antonio P. Strafella [Canada] | Movement disorders 2:Imaging insights into basal ganglia function, Parkinson's disease, and dystonia |
| 000C55 |
Lisa Kuramoto [Canada] ; Jacquelyn Cragg [Canada] ; Ramachandiran Nandhagopal [Canada] ; Edwin Mak [Canada] ; Vesna Sossi [Canada] ; Raul De La Fuente-Fernández [Canada] ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada] | The Nature of Progression in Parkinson’s Disease: An Application of Non-Linear, Multivariate, Longitudinal Random Effects Modelling |
| 000E14 |
Carles Vilari O-Güell [Canada] ; Alex Rajput ; Austen J. Milnerwood [Canada] ; Brinda Shah [Canada] ; Chelsea Szu-Tu [Canada] ; Joanne Trinh [Canada] ; Irene Yu [Canada] ; Mary Encarnacion [Canada] ; Lise N. Munsie [Canada] ; Lucia Tapia [Canada] ; Emil K. Gustavsson [Canada] ; Patrick Chou [Canada] ; Igor Tatarnikov [Canada] ; Daniel M. Evans [Canada] ; Frederick T. Pishotta [Canada] ; Mattia Volta [Canada] ; Dayne Beccano-Kelly [Canada] ; Christina Thompson [Canada] ; Michelle K. Lin [Canada] ; Holly E. Sherman [Canada] ; Heather J. Han [Canada] ; Bruce L. Guenther [Canada] ; Wyeth W. Wasserman [Canada] ; Virginie Bernard [Canada] ; Colin J. Ross [Canada] ; Silke Appel-Cresswell [Canada] ; A. Jon Stoessl [Canada] ; Christopher A. Robinson [Canada] ; Dennis W. Dickson ; Owen A. Ross ; Zbigniew K. Wszolek [États-Unis] ; Jan O. Aasly [Norvège] ; Ruey-Meei Wu [Taïwan] ; Faycal Hentati [Tunisie] ; Rachel A. Gibson [Royaume-Uni] ; Peter S. Mcpherson [Canada] ; Martine Girard [Canada] ; Michele Rajput ; Ali H. Rajput ; Matthew J. Farrer [Canada] | DNAJC13 mutations in Parkinson disease |
| 000E93 |
Silke Appel-Cresswell [Canada] ; Carles Vilarino-Guell [Canada] ; Mary Encarnacion [Canada] ; Holly Sherman [Canada] ; Irene Yu [Canada] ; Brinda Shah [Canada] ; David Weir [Canada] ; Christina Thompson [Canada] ; Chelsea Szu-Tu [Canada] ; Joanne Trinh [Canada] ; Jan O. Aasly [Norvège] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; A. Jon Stoessl [Canada] ; Matthew J. Farrer [Canada] | Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease |
| 001021 |
Pankaj A. Agarwal [Canada] ; A. Jon Stoessl [Canada] | Biomarkers for trials of neuroprotection in Parkinson's disease |
| 001059 |
Danielle Murray [Canada] ; A. Jon Stoessl [Canada] | Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions |
| 001078 |
Madeleine E. Sharp [Canada] ; Jayalakshmi Viswanathan [Canada] ; Martin J. Mckeown [Canada] ; Silke Appel-Cresswell [Canada] ; A. Jon Stoessl [Canada] ; Jason J. S. Barton [Canada] | Decisions under risk in Parkinson's disease: Preserved evaluation of probability and magnitude |
| 001263 |
Selina Wray [Royaume-Uni] ; Matthew Self [États-Unis] ; Patrick A. Lewis [Royaume-Uni] ; Jan-Willem Taanman [Royaume-Uni] ; Natalie S. Ryan [Royaume-Uni] ; Colin J. Mahoney [Royaume-Uni] ; Yuying Liang [Royaume-Uni] ; Michael J. Devine [Royaume-Uni] ; Una-Marie Sheerin [Royaume-Uni] ; Henry Houlden [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] ; Daniel Healy [Royaume-Uni] ; Jose-Felix Marti-Masso [Espagne] ; Elisavet Preza [Royaume-Uni] ; Suzanne Barker [Royaume-Uni] ; Margaret Sutherland [États-Unis] ; Roderick A. Corriveau [États-Unis] ; Michael D'Andrea [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Ryan J. Uitti [États-Unis] ; Mark Guttman [Canada] ; Grzegorz Opala [Pologne] ; Barbara Jasinska-Myga [Pologne] ; Andreas Puschmann [Suède] ; Christer Nilsson [Suède] ; Alberto J. Espay [États-Unis] ; Jaroslaw Slawek [Pologne] ; Ludwig Gutmann [États-Unis] ; Bradley F. Boeve [États-Unis] ; Kevin Boylan [États-Unis] ; A. Jon Stoessl [Canada] ; Owen A. Ross [États-Unis] ; Nicholas J. Maragakis [États-Unis] ; Jay Van Gerpen [États-Unis] ; Melissa Gerstenhaber [États-Unis] ; Katrina Gwinn [États-Unis] ; Ted M. Dawson [États-Unis] ; Ole Isacson [États-Unis] ; Karen S. Marder [États-Unis] ; Lorraine N. Clark [États-Unis] ; Serge E. Przedborski [États-Unis] ; Steven Finkbeiner [États-Unis] ; Jeffrey D. Rothstein [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Martin N. Rossor [Royaume-Uni] ; John Hardy [Royaume-Uni] | Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research |
| 001310 |
Jana Godau [Allemagne] ; Anna Hussl [Autriche] ; Praween Lolekha [Canada] ; A. Jon Stoessl [Canada] ; Klaus Seppi [Autriche] | Neuroimaging: Current role in detecting pre‐motor Parkinson's disease |
| 001825 |
A. Jon Stoessl [Canada] ; David J. Brooks [Royaume-Uni] ; David Eidelberg [États-Unis] | Milestones in neuroimaging |
| 001891 |
Raúl De La Fuente-Fernández [Canada] ; Michael Schulzer [Canada] ; Lisa Kuramoto [Canada] ; Jacquelyn Cragg [Canada] ; Nandhagopal Ramachandiran [Canada] ; Wing L. Au [Canada] ; Edwin Mak [Canada] ; Jess Mckenzie [Canada] ; Siobhan Mccormick [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Chong S. Lee [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Age‐specific progression of nigrostriatal dysfunction in Parkinson's disease |
| 001938 |
Ramachandiran Nandhagopal [Canada] ; Lisa Kuramoto [Canada] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Jacqueline Cragg [Canada] ; Jess Mckenzie [Canada] ; Siobhan Mccormick [Canada] ; Thomas J. Ruth [Canada] ; Vesna Sossi [Canada] ; Raul De La Fuente-Fernandez [Canada] ; A. Jon Stoessl [Canada] | Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease |
| 001965 |
Raúl De La Fuente-Fernandez [Canada] ; Michael Schulzer [Canada] ; Lisa Kuramoto [Canada] ; Jacquelyn Cragg [Canada] ; Nandhagopal Ramachandiran [Canada] ; Wing L. Au [Canada] ; Edwin Mak [Canada] ; Jess Mckenzie [Canada] ; Siobhan Mccormick [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Chong S. Lee [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Age-Specific Progression of Nigrostriatal Dysfunction in Parkinson's Disease |
| 001C41 |
André R. Troiano [Canada] ; Michael Schulzer [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Edwin Mak [Canada] ; Jess Mckenzie [Canada] ; Vesna Sossi [Canada] ; Siobhan Mccormick [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Dopamine transporter PET in normal aging: Dopamine transporter decline and its possible role in preservation of motor function |
| 001C52 |
A. Jon Stoessl [Canada] | Continuous dopaminergic therapy in Parkinson disease: Time to stride back? |
| 001D19 |
Sarah C. Lidstone [Canada] ; Michael Schulzer [Canada] ; Katherine Dinelle [Canada] ; Edwin Mak [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Anthony G. Phillips [Canada] ; A. Jon Stoessl [Canada] | Effects of Expectation on Placebo-Induced Dopamine Release in Parkinson Disease |
| 002107 |
Vesna Sossi [Canada] ; Katherine Dinelle [Canada] ; Geoffrey J. Topping [Canada] ; James E. Holden [États-Unis] ; Doris Doudet [Canada] ; Michael Schulzer [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] ; Raul De La Fuente-Femandez [Canada] | Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's : an in vivo imaging study |
| 002114 |
C. Warren Olanow [États-Unis] ; Jean-Michel Gracies [États-Unis] ; Christopher G. Goetz [États-Unis] ; A. Jon Stoessl [Canada] ; Thomas Freeman [États-Unis] ; Jeffrey H. Kordower [États-Unis] ; James Godbold [États-Unis] ; Jose A. Obeso [Espagne] | Clinical Pattern and Risk Factors for Dyskinesias Following Fetal Nigral Transplantation in Parkinson's Disease : A Double Blind Video-Based Analysis |
| 002160 |
Christian Wider [États-Unis] ; Dennis W. Dickson [États-Unis] ; A. Jon Stoessl [Canada] ; Yoshio Tsuboi [Japon] ; Françoise Chapon [France] ; Ludwig Gutmann [États-Unis] ; Bernard Lechevalier [France] ; Donald B. Calne [Canada] ; David A. Personett [États-Unis] ; Mary Hulihan [États-Unis] ; Jennifer Kachergus [États-Unis] ; Rosa Rademakers [États-Unis] ; Matthew C. Baker [États-Unis] ; Linda L. Grantier [Canada] ; O. K. Sujith [Canada] ; Laura Brown [États-Unis] ; Susan Calne [Canada] ; Matthew J. Farrer [États-Unis] ; Zbigniew K. Wszolek [États-Unis] | Pallidonigral TDP-43 pathology in Perry syndrome |
| 002194 |
Kazuko Hasegawa [Japon] ; A. Jon Stoessl [Canada] ; Teruo Yokoyama [Japon] ; Hisayuki Kowa [Japon] ; Zbigniew K. Wszolek [États-Unis] ; Saburo Yagishita [Japon] | Familial Parkinsonism: Study of Original Sagamihara PARK8 (I2020T) Kindred With Variable Clinicopathologic Outcomes |
| 002335 |
W. R. Wayne Martin ; Marguerite Wieler ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada] | Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease |
| 002397 |
R. Nandhagopal [Canada] ; Martin J. Mckeown [Canada] ; A. Jon Stoessl [Canada] | Invited Article : Functional imaging in Parkinson disease |
| 002525 |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa |
| 002567 |
Steven A. Gunzler [États-Unis] ; A. Jon Stoessl [Canada] ; Robert A. Egan [États-Unis] ; Richard G. Weleber [États-Unis] ; Paul Wang [États-Unis] ; John G. Nutt [États-Unis] | Joubert syndrome surviving to adulthood associated with a progressive movement disorder |
| 002569 |
Ronald B. Postuma [Canada] ; Christina Wolfson [Canada] ; Ali Rajput [Canada] ; A. Jon Stoessl [Canada] ; W. R. Wayne Martin [Canada] ; Oksana Suchowersky [Canada] ; Sylvain Chouinard [Canada] ; Michel Panisset [Canada] ; Mandar S. Jog [Royaume-Uni] ; David A. Grimes [Canada] ; Connie Marras [Canada] ; Anthony E. Lang [Canada] | Is there seasonal variation in risk of Parkinson's disease? |
| 002590 |
Vesna Sossi [Canada] ; Raúl De La Fuente-Fernández [Espagne] ; Michael Schulzer [Canada] ; Andre R. Troiano [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study |
| 002645 |
A. Jon Stoessl [Canada] ; Michael G. Kaplitt [États-Unis] ; Andrew Feigin [États-Unis] ; Chengke Tang [États-Unis] ; Helen L. Fitzsimons ; Paul Mattis [États-Unis] ; Patricia A. Lawlor [Nouvelle-Zélande] ; Ross J. Bland ; Deborah Young [Nouvelle-Zélande] ; Kristin Strybing [États-Unis] ; David Eidelberg [États-Unis] ; Matthew J. During [États-Unis, Nouvelle-Zélande] | Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease : an open label, phase I trial. Commentary |
| 002803 |
Anthony E. Lang [Canada] ; Steven Gill [Royaume-Uni] ; Nik K. Patel [Royaume-Uni] ; Andres Lozano [Canada] ; John G. Nutt [États-Unis] ; Richard Penn [États-Unis] ; David J. Brooks [Royaume-Uni] ; Gary Hotton [Royaume-Uni] ; Elena Moro [Canada] ; Peter Heywood [Canada] ; Matthew A. Brodsky [États-Unis] ; Kim Burchiel [États-Unis] ; Patrick Kelly [États-Unis] ; Arif Dalvi [États-Unis] ; Burton Scott [États-Unis] ; Mark Stacy [États-Unis] ; Dennis Turner [États-Unis] ; V. G. Frederich Wooten [États-Unis] ; William J. Elias [États-Unis] ; Edward R. Laws [États-Unis] ; Vijay Dhawan [États-Unis] ; A. Jon Stoessl [Canada] ; James Matcham [Royaume-Uni] ; Robert J. Coffey [États-Unis] ; Michael Traub [États-Unis] | Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease |
| 002816 |
Kaveh M. Koochesfahani [Canada] ; Raúl De La Fuente-Fernández [Canada, Espagne] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Lakshmi N. Yatham [Canada] ; Thomas J. Ruth [Canada] ; Stephan Blinder [Canada] ; A. Jon Stoessl [Canada] | Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: Positron emission tomographic studies |
| 002843 |
Rodrigo Mercado [Canada] ; Constantine Constantoyannis [Canada] ; Tomasz Mandat [Canada] ; Ajit Kumar [Canada] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada] | Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation |
| 002A55 |
A. Jon Stoessl [Canada] ; Patrick L. Mcgeer [Canada] | Hot spots: Can positron emission tomography offer insights into the pathogenesis of PD? |
| 002B07 |
Anthony E. Lang [Canada] ; Janis Miyasaki [Canada] ; C. Warren Olanow [Canada] ; A. Jon Stoessl [Canada] ; Oksana Suchowersky [Canada] | Progress in clinical neurosciences : A forum on the early management of Parkinson's disease |
| 002B09 |
WING LOK AU [Canada] ; John R. Adams [Canada] ; André R. Troiano [Canada] ; A. Jon Stoessl [Canada] | Parkinson's disease : in vivo assessment of disease progression using positron emission tomography |
| 002C10 |
Constantine Constantoyannis [Canada] ; Ajit Kumar [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada] | Tremor induced by thalamic deep brain stimulation in patients with complex regional facial pain |
| 002C31 |
Sarah Furtado [Canada] ; Haydeh Payami [États-Unis] ; Paul J. Lockhart [États-Unis] ; Melissa Hanson [États-Unis] ; John G. Nutt [États-Unis] ; Andrew A. Singleton [États-Unis] ; Amanda Singleton [États-Unis] ; Jamel Bower [États-Unis] ; Ryan J. Utti [États-Unis] ; Thomas D. Bird [États-Unis] ; Raul De La Fuente-Fernandez [Canada] ; Yoshio Tsuboi [États-Unis] ; Mary L. Klimek [Canada] ; Oksana Suchowersky [Canada] ; John Hardy [États-Unis] ; Donald B. Calne [Canada] ; Zbigniew K. Wszolek [États-Unis] ; Matthew Farrer [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; A. Jon Stoessl [Canada] | Profile of families with parkinsonism‐predominant spinocerebellar ataxia type 2 (SCA2) |
| 002C32 |
Rau L De La Fuente-Ferna Ndez [Canada, Espagne] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Presynaptic mechanisms of motor fluctuations in Parkinson’s disease: a probabilistic model |
| 002C55 |
Rau L De La Fuente-Ferna Ndez [Canada] ; Vesna Sossi [Canada] ; Zhigao Huang [Canada] ; Sarah Furtado [Canada] ; Jian-Qiang Lu [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias |
| 002D08 |
Raul De La Fuente-Fernandez [Canada, Espagne] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model |
| 002D13 |
Raul De La Fuente-Fernandez [Canada, Espagne] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada] | Placebo mechanisms and reward circuitry: Clues from Parkinson's disease |
| 002D22 |
Raul De La Fuente-Fernandez [Canada] ; Vesna Sossi [Canada] ; ZHIGAO HUANG [Canada] ; Sarah Furtado [Canada] ; Jian-Qiang Lu [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias |
| 002D25 |
Chong S. Lee [Canada] ; Michael Schulzer [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Edwin Mak [Canada] ; Lisa Kuramoto [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Lack of Regional selectivity during the progression of Parkinson disease: Implications for pathogenesis |
| 002D43 |
Ajit Kumar [Canada] ; Susan M. Calne [Canada] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Zbigniew Wszolek [États-Unis] ; Chris Van Netten [Canada] ; Joseph K. C. Tsui [Canada] ; A. Jon Stoessl [Canada] ; Donald B. Calne [Canada] | Clustering of Parkinson disease: Shared cause or coincidence? |
| 002E06 |
Raúl De La Fuente-Fernández [Canada] ; Andrew S. Lim [Canada] ; Vesna Sossi [Canada] ; Michael J. Adam [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] ; Chong S. Lee [Canada] | Age and severity of nigrostriatal damage at onset of Parkinson's disease |
| 002E08 |
Ajit Kumar ; Sharanpal Mann ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl ; Michael Schulzer ; Chong S. Lee | [11C]DTBZ‐PET correlates of levodopa responses in asymmetric Parkinson’s disease |
| 002E13 |
Raúl De La Fuente-Fernández [Canada] ; Sarah Furtado [Canada] ; Mark Guttman [Canada] ; Yoshiaki Furukawa [Canada] ; Chong S. Lee [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | VMAT2 binding is elevated in dopa‐responsive dystonia: Visualizing empty vesicles by PET |
| 002E27 |
Alan L. Whone [Royaume-Uni] ; Ray L. Watts [États-Unis] ; A. Jon Stoessl [Canada] ; Margaret Davis [États-Unis] ; Sven Reske [Allemagne] ; Claude Nahmias ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Maria J. Ribeiro [France] ; Philippe Remy [France] ; Werner Poewe [Autriche] ; Robert A. Hauser [États-Unis] ; David J. Brooks [Royaume-Uni] | Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study |
| 002E89 |
C. Warren Olanow [États-Unis] ; Christopher G. Goetz [États-Unis] ; Jeffrey H. Kordower [États-Unis] ; A. Jon Stoessl [Canada] ; Vesna Sossi [Canada] ; Mitchell F. Brin [États-Unis] ; Kathleen M. Shannon [États-Unis] ; G. Michael Nauert [États-Unis] ; Daniel P. Perl [États-Unis] ; James Godbold [États-Unis] ; Thomas B. Freeman [États-Unis] | A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease |
| 002E91 |
Ajit Kumar [Canada] ; Sharanpal Mann [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada] ; Chong S. Lee [Canada] | [11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease |
| 002F27 |
Lisa M. Inkster [Canada] ; Janice J. Eng [Canada] ; Donna L. Macintyre [Canada] ; A. Jon Stoessl [Canada] | Leg muscle strength is reduced in Parkinson's disease and relates to the ability to rise from a chair |
| 002F35 |
ZHIGAO HUANG [Canada] ; Raul De La Fuente-Fernandez [Canada] ; A. Jon Stoessl [Canada] | Etiology of Parkinson's disease |
| 002F40 |
A. Jon Stoessl [Canada] ; Raul De La Fuente-Fernandez [Canada] | Dopamine receptors in Parkinson's disease: Imaging studies |
| 002F94 |
Pramod K. Pal [Canada] ; Joanne Leung [États-Unis] ; Katya Hedrich [Allemagne] ; Ali Samii [Canada] ; Abraham Lieberman [États-Unis] ; Paul A. Nausieda [États-Unis] ; Donald B. Calne [Canada] ; Xandra O. Breakefield [États-Unis] ; Christine Klein [Allemagne] ; A. Jon Stoessl [Canada] | [18F]‐Dopa positron emission tomography imaging in early‐stage, non‐parkin juvenile parkinsonism |
| 003091 |
Raul De La Fuente-Fernandez [Canada] ; Anthony G. Phillips [Canada] ; Mariangela Zamburlini [Canada] ; Vesna Sossi [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Dopamine release in human ventral striatum and expectation of reward |
| 003257 |
Raúl De La Fuente-Fernández [Canada] ; Jian-Qiang Lu [Canada] ; Vesna Sossi [Canada] ; Salma Jivan [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Chong S. Lee [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover |
| 003296 |
A. Jon Stoessl [Canada] | Neurochemical and neuroreceptor imaging with PET in Parkinson's disease |
| 003326 |
Raul De La Fuente-Fernandez [Canada] ; Thomas J. Ruth [Canada] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Expectation and dopamine release: Mechanism of the placebo effect in Parkinson's disease |
| 003351 |
Raul De La Fuente-Fernandez [Canada] ; Jian-Qiang Lu [Canada] ; Vesna Sossi [Canada] ; Salma Jivan [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Chong S. Lee [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease : PET evidence of increased dopamine turnover |
| 003353 |
Raul De La Fuente-Fernandez [Canada] ; Andrew S. Lim [Canada] ; Vesna Sossi [Canada] ; James E. Holden [États-Unis] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Apomorphine-induced changes in synaptic dopamine levels : Positron emission tomography evidence for presynaptic inhibition |
| 003466 |
Raúl De La Fuente-Fernández [Canada] ; Asha Kishore [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Nigrostriatal dopamine system and motor lateralization |
| 003485 |
Chong S. Lee [Canada] ; Ali Samii [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Jess Wudel [Canada] ; Pramod K. Pal [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease |
| 003513 |
J. M. Van Kampen [Canada] ; E. G. Mcgeer [Canada] ; A. Jon Stoessl [Canada] | Dopamine transporter function assessed by antisense knockdown in the rat: Protection from dopamine neurotoxicity |
| 003A07 |
Yue Wang [Canada] ; Grace L. Y. Chan [Canada] ; James E. Holden [États-Unis] ; Teresa Dobko [Canada] ; Edwin Mak [Canada] ; Michael Schulzer [Canada] ; Joseph M. Huser [Canada] ; Barry J. Snow [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Age‐dependent decline of dopamine D1 receptors in human brain: A PET study |
| 003D23 |
A. Jon Stoessl [Canada] | Which dopamine receptor(s) do we need for motor function? Lessons from gene targeting and translational blockade |
| 004F55 |
A. Jon Stoessl [Canada] ; E. Mak [Canada] ; Donaldb. Calne [Canada] | (+)-4-PROPYL-9-HYDROXYNAPHTHOXAZINE (PHNO), A NEW DOPAMINOMIMETIC, IN TREATMENT OF PARKINSONISM |
